Outset Medical (OM) Change in Receivables (2019 - 2026)
Outset Medical's (OM) quarterly Change in Receivables came in at -$3.4 million in Q1 2026, down 332.38% year-on-year from $1.5 million in Q1 2025, and down 92.82% on a QoQ basis from -$1.8 million in Q4 2025.
Outset Medical (OM) Change in Receivables (2019 - 2026) Analysis & Trends
Outset Medical (OM) has 8 years of Change in Receivables data on file, last reported at -$3.4 million in Q1 2026.
- On a quarterly basis, Change in Receivables fell 332.38% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$8.7 million, a 390.11% decrease from a year earlier, with the FY2025 full-year figure at -$3.8 million, down 175.32% from the prior year.
- Change in Receivables for Q1 2026 stood at -$3.4 million, down from -$1.8 million in the prior quarter.
- Over the last five years, Change in Receivables for OM reached as high as $6.2 million in Q1 2023 and fell as low as -$3.4 million in Q1 2026.
- Historically, Change in Receivables has averaged $319294.1 across 5 years, with a median of -$544000.0 in 2024.
- Across the five-year window, Change in Receivables surged 379.14% in 2023 and plunged 2186.33% in 2025, its largest moves.
- Year by year, Change in Receivables stood at $5.6 million in 2022, then sank by 144.23% to -$2.5 million in 2023, then soared by 177.73% to $1.9 million in 2024, then tumbled by 192.08% to -$1.8 million in 2025, then tumbled by 92.82% to -$3.4 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were -$3.4 million in Q1 2026, -$1.8 million in Q4 2025, and -$2.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.39 Bn | 175.10 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.87 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 108.59 Bn | 99.37 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 68.22 Bn | 66.77 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 28.58 Bn | 27.46 Bn | 750.30 Mn | -124.60 Mn |
| 7 | GE HealthCare Technologies | 28.48 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | - |
| 10 | Outset Medical | 77,625.92 | -286.57 Mn | 12.10 Mn | -3.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.41 Mn |
| Mar 31, 2026 | -3.41 Mn |
| Dec 31, 2025 | -1.77 Mn |
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Sep 30, 2025 | -2.90 Mn |
| Jun 30, 2025 | -574,000.00 |
| Jun 30, 2025 | -574,000.00 |
| Mar 31, 2025 | 1.47 Mn |
| Mar 31, 2025 | 1.47 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 139,000.00 |
| Sep 30, 2024 | 139,000.00 |
| Jun 30, 2024 | -544,000.00 |
| Jun 30, 2024 | -544,000.00 |
| Mar 31, 2024 | 3.50 Mn |
| Mar 31, 2024 | 3.50 Mn |
| Dec 31, 2023 | -2.47 Mn |
| Dec 31, 2023 | -2.47 Mn |